1 - 6 of 6

Jason P. Van Batavia, MD

Photo of Jason P. Van Batavia

Dr. Van Batavia's long-term goal is to become a leader in neuro-urology and lower urinary tract dysfunction, with particular emphasis on deciphering the pathophysiology of lower urinary tract dysfunction and translating developments in the basic science arena into clinical improvements for patients.


Johannes C.M. van der Loo, PhD

Johannes C.M. van der Loo

Dr. van der Loo is an Adjunct Associate Professor of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania and Director of the Clinical Vector Core at CHOP, focusing on manufacturing of GMP and GMP process-comparable AAV and Lentiviral vectors for preclinical and gene therapy early phase clinical studies.


Adeline L. Vanderver, MD

Photo of Adeline Vanderver

Using translational approaches that encompass genomic studies, biomarker development, disease modeling, natural history studies, and clinical trials, Dr. Vanderver seeks to improve the quality of life and lifespan of individuals living with leukodystrophies or heritable disorder of myelin. She leads the Leukodystrophy Center of Excellence at Children's Hospital of Philadelphia.